Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-241999

Chief Executive Officer acquired 3,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Weis Holger Chief Executive Officer 2026-05-22 Grant or award +3,700 $2.37 $8,769 4,911 D: show line 1 in the form
Loading xslF345X06/ownership.xml…